---
title: "ICOS blockade reduces intratumoral Treg suppression in triple-negative breast cancer"
id: "biorxiv-2-icos-blockade-alleviates-immune-suppression-in-breast-tumor-microenvironment"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-2-icos-blockade-alleviates-immune-suppression-in-breast-tumor-microenvironment"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.10.22.760908v1?rss=1"
published_at: "2026-10-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ICOS blockade reduces intratumoral Treg suppression in triple-negative breast cancer
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-2-icos-blockade-alleviates-immune-suppression-in-breast-tumor-microenvironment
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.10.22.760908v1?rss=1)
- **Published At:** 2026-10-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators found **ICOS** selectively upregulated on tumor-infiltrating **regulatory T cells** (Tregs) in breast cancer, with evidence across imaging and single-cell datasets. - The cohort analysis included 1,359 tumor regions from 279 triple-negative breast cancer patients profiled by imaging mass cytometry; complementary single-cell transcriptomes derived from 129 breast cancer donors. - Data indicated spatial colocalization of ICOS+ Tregs with exhausted CD8+ T cells within a defined tumor niche, suggesting a localized immunoregulatory microenvironment. - Genetic deletion or pharmacologic blockade of ICOS disrupted the intratumoral Treg program, reduced Treg activation and tissue-residency signatures, and expanded cytotoxic CD8+ T cells with a tissue-resident memory phenotype. - In syngeneic orthotopic breast cancer models, ICOS blockade limited primary tumor growth, reduced spontaneous metastasis, and prolonged survival while investigators reported no disruption of systemic immune homeostasis. - Therapeutic benefit was observed with both neoadjuvant and adjuvant scheduling in preclinical models; combined ICOS and **PD-1** blockade produced greater tumor control than either approach alone. - The source did not report clinical dosing, safety data in humans, or detailed trial parameters; those remain to be defined for translation to patients. - Authors proposed ICOS blockade as a strategy to augment checkpoint immunotherapy, with remaining questions about clinical safety, optimal combination regimens, and patient selection biomarkers.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.10.22.760908v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.10.22.760908v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # ICOS blockade alleviates immune suppression in breast tumor microenvironment Shalini Guleria, [ View ORCID Profile](http://orcid.org/0000-0003-1542-5100)Chamikara Dushmantha Liyanage, [ View ORCID Profile](http://orcid.org/0009-0001-6242-4269)William John Hutchison, Kurtis Treller, [ View ORCID Profile](http://orcid.org/0009-0002-2534-1584)Liam Neil, [ View ORCID Profile](http://orcid.org/0000-0002-0960-4519)Yingnan Gao, [ View ORCID Profile](http://orcid.org/0000-0002-9218-9917)Belinda Yeo, [ View ORCID Profile](http://orcid.org/0000-0001-9123-7684)John M Mariadason, [ View ORCID Profile](http://orcid.org/0000-0002-6312-6968)Axel Kallies, [ View ORCID Profile](http://orcid.org/0000-0002-9891-5078)Conor J Kearney, [ View ORCID Profile](http://orcid.org/0000-0002-9522-9320)Lisa A Mielke, [ View ORCID Profile](http://orcid.org/0000-0002-4913-5999)Sadanand Vodala, [ View ORCID Profile](http://orcid.org/0000-0002-6841-7422)Robin L Anderson, [ View ORCID Profile](http://orcid.org/0000-0002-8075-6275)Delphine Merino, [ View ORCID Profile](http://orcid.org/0000-0002-1102-8506)Anthony T Papenfuss, [ View ORCID Profile](http://orcid.org/0000-0003-2345-2846)Vijay K Yadav, [ View ORCID Profile](http://orcid.org/0000-0002-1620-7781)Ajithkumar Vasanthakumar, [ View ORCID Profile](http://orcid.org/0000-0001-7474-836X)Stefano Mangiola, [ View ORCID Profile](http://orcid.org/0000-0002-3684-4331)Bhupinder Pal doi: https://doi.org/10.64898/2026.10.22.760908 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Shalini Guleria 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shalini%2BGuleria%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Guleria%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AShalini%2BGuleria%2B) Chamikara Dushmantha Liyanage 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chamikara%2BDushmantha%2BLiyanage%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Liyanage%20CD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChamikara%2BDushmantha%2BLiyanage%2B) * [ORCID record for Chamikara Dushmantha Liyanage](http://orcid.org/0000-0003-1542-5100 "Open in new tab") William John Hutchison 2 The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; University of Melbourne, Melbourne, Victoria, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=William%2BJohn%2BHutchison%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hutchison%20WJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AWilliam%2BJohn%2BHutchison%2B) * [ORCID record for William John Hutchison](http://orcid.org/0009-0001-6242-4269 "Open in new tab") Kurtis Treller 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kurtis%2BTreller%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Treller%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AKurtis%2BTreller%2B) Liam Neil 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Liam%2BNeil%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Neil%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALiam%2BNeil%2B) * [ORCID record for Liam Neil](http://orcid.org/0009-0002-2534-1584 "Open in new tab") Yingnan Gao 3 South Australian immunoGENomics Cancer Institute, Adelaide, South Australia 5005, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yingnan%2BGao%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Gao%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYingnan%2BGao%2B) * [ORCID record for Yingnan Gao](http://orcid.org/0000-0002-0960-4519 "Open in new tab") Belinda Yeo 4 Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; Austin Health, Heidelberg, VIC, 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Belinda%2BYeo%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Yeo%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ABelinda%2BYeo%2B) * [ORCID record for Belinda Yeo](http://orcid.org/0000-0002-9218-9917 "Open in new tab") John M Mariadason 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=John%2BM%2BMariadason%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Mariadason%20JM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJohn%2BM%2BMariadason%2B) * [ORCID record for John M Mariadason](http://orcid.org/0000-0001-9123-7684 "Open in new tab") Axel Kallies 5 Peter Doherty Institute for Infection and Immunity, Parkville VIC, 3000, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Axel%2BKallies%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kallies%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAxel%2BKallies%2B) * [ORCID record for Axel Kallies](http://orcid.org/0000-0002-6312-6968 "Open in new tab") Conor J Kearney 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Conor%2BJ%2BKearney%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kearney%20CJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AConor%2BJ%2BKearney%2B) * [ORCID record for Conor J Kearney](http://orcid.org/0000-0002-9891-5078 "Open in new tab") Lisa A Mielke 6 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lisa%2BA%2BMielke%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Mielke%20LA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALisa%2BA%2BMielke%2B) * [ORCID record for Lisa A Mielke](http://orcid.org/0000-0002-9522-9320 "Open in new tab") Sadanand Vodala 7 Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sadanand%2BVodala%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Vodala%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASadanand%2BVodala%2B) * [ORCID record for Sadanand Vodala](http://orcid.org/0000-0002-4913-5999 "Open in new tab") Robin L Anderson 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robin%2BL%2BAnderson%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Anderson%20RL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ARobin%2BL%2BAnderson%2B) * [ORCID record for Robin L Anderson](http://orcid.org/0000-0002-6841-7422 "Open in new tab") Delphine Merino 1 School of Cancer Medicine, La Trobe University, Bundoora Vic 3086, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg Vic 3084, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Delphine%2BMerino%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Merino%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADelphine%2BMerino%2B) * [ORCID record for Delphine Merino](http://orcid.org/0000-0002-8075-6275 "Open in new tab") Anthony T Papenfuss 2 The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; University of Melbourne, Melbourne, Victoria, Australia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anthony%2BT%2BPapenfuss%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Papenfuss%20AT&link_type=AUTHORSEARCH "Open in ne
## Related Clinical Research

- [Spatially informed computational model predicts which breast-to-lung metastases respond to dual ch](https://medichelpline.com/clinical-feed/biorxiv-4-computational-modeling-of-breast-cancer-metastases-predicts-response-to-dual.md)
- [Phenotype-cloud Reorganization in Cancer — Preprint Details and Access](https://medichelpline.com/clinical-feed/biorxiv-0-phenotype-cloud-reorganization-shapes-cancer-progression-and-therapeutic.md)
- [Pope Leo XIV Diagnosed with Lung Adenocarcinoma: Key Insights](https://medichelpline.com/clinical-feed/medical-news-today-0-pope-leo-lung-cancer-diagnosis-what-to-know-about-lung-adenocarcinoma.md)
- [Structured aerobic exercise linked to lower cancer recurrence and improved survival](https://medichelpline.com/clinical-feed/medical-news-today-0-aerobic-exercise-could-help-improve-outlook-after-cancer-treatment.md)
- [Induced proximity therapies: PROTACs, molecular glues and RIPTACs in oncology](https://medichelpline.com/clinical-feed/nature-3-induced-proximity-comes-of-age.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.